Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine the role of inflammation in the high prevalence of psychiatric disorders in skin-restricted lupus (SRL) patients. SRL is an inflammatory disease. Inflammation can lead to a decrease in the synthesis of neurotransmitters via the activation of the IDO enzyme and to induce the synthesis of neurotoxic molecules (kynurenin pathway). This leads to the development of psychiatric disorders. Investigator therefore want to compare inflammation and neurotransmitter synthesis in SRL patients according to the presence or absence of psychiatric disorders. Investigator expect a decrease in neurotransmitter synthesis and activation of the kynurenin pathway in patients with a psychiatric disorder.


Clinical Trial Description

The purpose of this study is to determine the role of inflammation in the high prevalence of psychiatric disorders in skin-restricted lupus (SRL) patients. SRL is an inflammatory disease. Inflammation can lead to a decrease in the synthesis of neurotransmitters via the activation of the IDO enzyme and to induce the synthesis of neurotoxic molecules (kynurenin pathway). This leads to the development of psychiatric disorders. Investigator therefore want to compare inflammation and neurotransmitter synthesis in SRL patients according to the presence or absence of psychiatric disorders. Investigator expect a decrease in neurotransmitter synthesis and activation of the kynurenin pathway in patients with a psychiatric disorder. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03125083
Study type Interventional
Source University Hospital, Clermont-Ferrand
Contact
Status Completed
Phase N/A
Start date May 5, 2017
Completion date October 24, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT00166764 - A Study on Evaluation of Mental Health Index of Patients With Psychiatric Disorders N/A
Recruiting NCT06062953 - Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients With Psychiatric Disorders and Comorbid Insomnia Phase 2/Phase 3
Recruiting NCT05548946 - A Dimensional Model for Personality Disorders in Later Life N/A
Completed NCT03313154 - Impact on QoL and Cognitive Functioning of New Antiviral Therapies in Subjects With Chronic Hepatitis HCV-related
Completed NCT00783783 - CYP2D6 Pharmacogenetics in Risperidone-Treated Children N/A
Completed NCT01989728 - Prevalence and Effect of Detecting Common Mental Disorders in Long-term Sickness Absence N/A
Recruiting NCT01066299 - Influence of Oxytocin on the Startle Reflex and on Its Modulation N/A
Completed NCT02987426 - Can Brief-mindfulness Interventions Improve Psychiatric Symptoms? Phase 2/Phase 3
Recruiting NCT05784818 - Up To Me: Erasing the Stigma of Mental Illness on College Campuses N/A
Completed NCT01786733 - Behavioral Activation - From Inpatient to Outpatient Services N/A
Withdrawn NCT03907124 - Clinical Utility of Pharmacogenomics of Psychotropic Medications Phase 4
Withdrawn NCT03809897 - Varenicline for Smoking Cessation in Hospitalized Patients With Psychiatric Disorders Phase 4
Not yet recruiting NCT02857322 - Effectiveness Accompaniment Perioperative Patients With Psychiatric Illness on the Lives Perioperative N/A
Terminated NCT02665988 - Adjunctive Transcranial Direct Current Stimulation N/A
Completed NCT01823250 - Culturally Informed Family Based Treatment of Adolescents: A Randomized Trial Phase 2
Completed NCT01289080 - Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired Subjects Phase 1
Active, not recruiting NCT00982943 - The Epidemiological Study on Psychiatric Disorders and Psychotropic Drugs N/A
Completed NCT00184340 - Secured Internet-mediated Psychotherapy With Psychiatry Patients N/A
Completed NCT00184327 - Changes Following Inpatient Child-oriented Family Treatment Phase 1
Recruiting NCT04381845 - Immunity and Infections in the Psychiatric Population N/A